2 Attractive Small-Cap Marijuana Stocks to Watch

Cannabis stocks have been severely beaten in the past few months. While the general sentiment is negative, there are still good values ​​to be found in the marijuana sector. The Valens Company (TSXV:VLNS) and MediPharm Labs (TSX:LABS) are two small-cap stocks that are showing strong growth and are still cheap. The Valens Company Valens is the third-largest Canadian extraction company…

Read More

This Small-Cap Pot Stock Beats Canopy to Profitability

When you think about marijuana stocks, you probably think about big names like Canopy Growth and Aurora Cannabis. These companies aren’t turning a profit yet and won’t be profitable any time soon. The first full year of cannabis legalization in Canada has been challenged by scandals, oversupply problems, and lack of visibility in retail. The factors all put downward pressure…

Read More

Cannabis May Not Rebound in 2020, but Aphria (TSX:APHA) Could Soar

Many pundits are predicting that after a rough 2019, cannabis stocks will bounce back in 2020. During 2019, the marijuana bubble burst, seeing many cannabis stocks plunge sharply over the course of the year, causing the industry’s largest exchange-traded fund (ETF), ETFMG Alternative Harvest ETF, to lose a whopping 35%, with its largest single holding Canopy Growth shedding the same…

Read More

Aurora Cannabis’s (TSX:ACB) Stock Price Underperforms CannTrust Holdings’s (TSX:TRST)

After a heavy beating in 2019, when cannabis firms’ shares fell 80% from their peak valuation to less than $2.80 at year-end, Aurora Cannabis’s (TSX:ACB)(NYSE:ACB) stock price hasn’t performed any better so far in 2020. Some investors may wish they had invested in an embattled CannTrust Holdings (TSX:TRST)(NYSE:CTST) in January this year instead. During the first 20 days of 2020,…

Read More

Is HEXO Stock a Buy After Restated Earnings?

Cannabis producer HEXO’s (TSX:HEXO)(NYSE:HEXO) stock has been on a strong rebound lately since the start of the new year and the share price closed nearly 16% higher on Wednesday as the pot industry received an Organigram Holdings powered valuation boost. The company recently filed restated financial reports for its fiscal year which ended July 31, 2019 as well as amended…

Read More

Should You Buy Organigram (TSX:OGI) Stock Today?

The fact that cannabis producer Organigram Holdings (TSX:OGI)(NASDAQ:OGI) delivered a 102% year-over-year net revenue growth for the recently reported first quarter of fiscal 2020 doesn’t move me as much as a 54% sequential sales increase over a recent previous quarter does. The year-over-year comparison pits one quarter with very little recreational pot sales generated in just one full month and…

Read More

Better Cannabis Buy: Green Organic Dutchman (TSX:TGOD) vs. OrganiGram (TSX:OGI)

Cannabis stocks continue to remain volatile, as we head into the last two months of 2019. Investors and analysts were upbeat about the strong demand for cannabis products after marijuana was legalized for recreational use last October. Further, the Cannabis 2.0 was supposed to drive stocks to their previous highs, if not more. Instead, it seems like analysts have grossly…

Read More

Could This Tiny Marijuana Stock Be a Better Bet Than Aurora Cannabis (TSX:ACB)?

Aurora Cannabis (TSX:ACB)(NYSE:ACB) had another terrible week, falling 7.9% between Monday and Thursday. It wasn’t the first losing week for the stock, which is down 19% year to date and 58% from its 52-week high. Although the recent news out of Aurora hasn’t been entirely terrible — with high growth and shrinking losses being positive points — it evidently hasn’t…

Read More

2 Underrated Pot Stocks to Buy Ahead of Cannabis 2.0

The bear came for cannabis stocks in the late spring and summer, but this has also created an opportunity for investors looking to jump into the fledgling sector. Many of the top producers still carry high valuations, but there are still mid-tier cannabis companies available that can be had for a bargain. Today, we’re going to take a snapshot of…

Read More